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ABSTRACT 
Background. Obesity is increasing globally and is defined as a Body Mass Index (BMI) 
over 30 kgms/m². It’s prevalence in the Metro West Maternity service is unknown. 
Objective .To assess the prevalence of obesity and determine its association with 
adverse  perinatal and maternal outcomes among pregnant women in the Metro West 
Region, Cape Town, South Africa 
 Study Design. This was a retrospective observational study that compared perinatal 
outcomes in women with normal pregnancyBMI to outcomes in women with high 
pregnancy BMI. 
Setting. Mitchells Plain and Guguletu Midwife Obstetric Units, Mowbray Maternity 
Hospital and Groote Schuur Hospital, Metro West Region, Cape Town, South Africa 
Population. A total of 970 pregnant women divided into BMI groups that had their first 
antenatal booking visit between January and April 2011.  
Methods.   A list of folder numbers was compiled from the antenatal booking registry at 
the two MOUs. From the list, maternal folders were then traced through the CLINICOM 
tracking system, MOU delivery registers, antenatal clinic transfer registers and labour 
ward transfer registers to find place of delivery or outcome of pregnancy. Maternal and 
perinatal characteristics were then extracted from the folders into the data collection 
sheet and data was analysed by STATA. Descriptive statistics included proportions with 
percentages and median with interquartile ranges. Inferential statistics included Chi- 
squared tests, Fisher Exact tests, Kruskal Wallis test, univariate and multivariable 
logistic regressions. 
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Main outcome measures. Perinatal outcomes (stillbirth, macrosomia, shoulder 
dystocia, 5 minute Apgar Score less than 7, congenital abnormalities) observed in obese 
and morbidly obese compared to normal BMI pregnant women. 
Results. Eight hundred and twenty pregnant women delivered at the MOUs, 120 at the 
level 2 institution and 30 at a tertiary institution. The 970 included 197 overweight 
women and 389 obese women, of which 118 were morbidly obese. The prevalence of 
obesity in the study population was 40.4%. Higher maternal age was associated with 
increased BMI (p=0.0001). HIV prevalence was 15.5% and obese women were more 
likely to be HIV positive (p=0.000).Perinatal outcomes of macrosomia (p < 0.000), 
shoulder dystocia (p< 0.000), perinatal death (p<0.000), Neonatal Intensive Care Unit 
(NICU) admission (p< 0.000), 5 minute Apgar score < 7 (p= 0.008), and congenital 
abnormalities (p<0.000) were all significantly more common in the morbidly obese 
women when compared with those with a normal BMI. The unadjusted odds ratios for 
preterm delivery were 0.71 (95% CI, 0.36-1.42), 1.27 (95% CI, 0.74-2.16) and 2.66 
(95% CI, 1.49-4.77) among overweight, obese and morbidly obese pregnant women 
respectively compared to normal weight pregnant women. Having accounted for age, 
parity, hypertension in pregnancy, gestational diabetes and HIV, morbidly obese women 
had high significant adjusted odds ratios for macrosomic deliveries 9.2(4.61-18.55), 
perinatal deaths 9.0 (3.04-27.04), shoulder dystocia 36.6 (8.94-149.40), ICU admission 
10.25 (4.82-23.95), preterm delivery 2.3 (1.2-4.15) and perinatal events 12.34 (7.02-
21.69).Maternal outcomes of caesarean section (p<0.000), third or fourth degree perineal 
tears (p=0.005), occurrence of hypertension and gestational diabetes in pregnancy 
(p<0.0000), and preterm delivery (p = 0.001) were significantly more common in the 
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morbidly obese group. In the morbidly obese pregnant women, 74.6% attained a vaginal 
delivery compared to 96.8% in the normal BMI group. Thromboembolic events (p = 
0.251) were not significantly higher among the high BMI group compared to the normal 
BMI group. 
Conclusion The prevalence of obesity in pregnancy in our population was high, and was 
associated with adverse perinatal outcomes, especially in the morbidly obese group. 
Adverse maternal outcomes were also more likely to occur in morbidly obese women 
than in women with a normal BMI. 
Keywords Body mass index, obesity, pregnancy, adverse perinatal outcomes, Cape 
Town, South Africa 
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INTRODUCTION 
The prevalence of obesity in the general population has risen to such an extent that it is 
now considered a worldwide epidemic. This has been recognized by the World Health 
Organization (WHO) 1. This increase has a direct impact on women of reproductive 
age¹. Over one billion adults worldwide are estimated to be overweight, with 400 million 
of these classified as obese.1,2 Approximately half of the women of reproductive age in 
the United States of America (USA) are either overweight or obese.1,2 South Africa has 
not been spared by this epidemic, as according to the South African Demographic 
Health Survey of 2003, 57% of women are classified as being either obese or 
overweight.3,4 Major contributing factors towards the high prevalence of obesity in 
South Africa have been  a shift in dietary intake to that of a higher fat intake, and 
generally reduced levels of physical activity. In addition, few overweight black women 
view themselves as overweight, and more recently, there is a social stigma of associating 
thinness to HIV/AIDS.3,4 The major public health impact of this obesity epidemic is the 
resultant increase in the prevalence of medical conditions such as type 2 diabetes and 
hypertension. This has consequently strained health care budgets, as instead of 
preventing these conditions, there is now a need to treat more affected people.4 
 
Obesity in pregnancy poses a great challenge, as it has been associated with undesirable 
outcomes. The recent finding of obesity occurring in one in five women at antenatal 
booking in the United Kingdom (UK) is concerning. 5 In the United States of America 
(USA), the prevalence of obesity during pregnancy increased significantly from 7 to 24 
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percent between 1991 and 2003, and currently is at 30.5%, whilst in South Africa, Basu 
et al found the prevalence of obesity in pregnancy to be 44%. 6-8  
 
The WHO has approved the use of body mass index (BMI) for the assessment of obesity 
in pregnancy.1 The justification for this is that BMI does not change significantly until 
the third trimester, and other assessment tools of obesity like skin fold thickness are not 
reliable in pregnancy as they are affected by alterations in body composition during 
pregnancy. BMI is calculated using maternal booking weight measurements in kilograms 
(kg) divided by maternal booking height in meters squared (m2) and expressed as kg/m². 
It is then classified in to the 5 groups as tabulated below: 1,6-8 
BMI (Kg/m2) CLASS 
≤18.49 Underweight 
18.5-24.9 Normal- ideal 
25.0-29.9 Overweight 
30.0-39.9 Obesity 
≥40.0 Morbidly obese 
 
   
Many studies have shown that obesity in pregnancy is associated with a wide spectrum 
of adverse pregnancy outcomes. These can be classified as maternal or perinatal. 
Adverse perinatal outcomes include an increased risk of congenital abnormalities; 
specifically neural tube and cardiac defects, an increased risk of preterm delivery, and 
higher rates of stillbirth.9-28 There is a higher prevalence of fetal macrosomia 
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(birthweight ≥4.0kg), which in turn can result in shoulder dystocia and subsequent 
trauma to both mother and baby. 29-30 Fetal macrosomia has also been shown to be a 
predisposing factor in the development of childhood obesity.25-26 
Adverse maternal outcomes include an increased risk of gestational hypertension and 
diabetes, a higher rate of caesarean section due to slow and prolonged labour, and 
increased postpartum complications such as postpartum haemorrhage, infection and 
thromboembolic events. 9-15,29-46  
 
Obesity in the general population has been declared a worldwide epidemic and its effects 
in pregnancy have been extensively studied in the western world. There is little data so 
far from sub Saharan Africa and in our setting in Cape Town, hence we decided to 
assess the impact of obesity on pregnancy outcomes. 
 
LITERATURE REVIEW 
Maternal and perinatal outcomes in obese pregnant women have been extensively 
studied in different populations and some of the literature is shown below. 
 
Assessment of obesity 
BMI is considered to be the best indicator of obesity in general and in pregnancy. It is 
the most frequently used tool for assessing obesity in pregnancy in research studies and 
is a better indicator of obesity than weight alone 5-8. In an ideal setting BMI should be 
measured between 10 -12 weeks gestation because this is the best indicator of pre-
pregnancy weight. 6-8 However, in poor resource settings like sub-Saharan Africa, many 
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women book for antenatal care after the first trimester; on average at 28 weeks8 and 69% 
of pregnant women have only one antenatal care visit in their entire pregnancy which is 
usually late on in pregnancy. 8,47-48  . This means that booking weight may reflect weight 
gain in pregnancy as well as pre pregnancy weight. This would be a particular problem 
in the third trimester since this is the period when maternal weight gain would have been 
greatest. 6-8  Given that the majority of women book in the second trimester, BMI 
estimation in this trimester, although having limitations, may be the only way of  
acquiring  a  baseline BMI measurement in pregnant women in our setting. A further 
limitation of obesity using BMI is that many antenatal clinics may not have weighing 
scales or height measuring devices. 47-48  
 
 
 Perinatal outcomes 
Maternal obesity has been associated with a small increase in the absolute rate of certain 
congenital anomalies, and this risk has been shown to rise with an increase in maternal 
weight.9-19 The underlying pathophysiology is unknown, but it is postulated that there is 
an altered nutritional environment for fetal development in obese women. A systematic 
review (39 studies) and meta-analysis (18 studies) showed that the odds of neural tube 
defects in obese women  compared to those with normal BMI was 1.87 [95% 
Confidence Interval (CI) 1.62-2.15], and that of cardiovascular anomalies was 1.30 [ 
95% CI 1.12-1.51]. 16 Another meta-analysis (12 case-control and cohort studies) 
showed that the risk of neural tube defects increased significantly with maternal weight. 
Compared with normal weight women, the odds of having a child with a neural tube 
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defect were as follows: overweight women [Odds Ratio (OR) 1.22; 95% CI 0.99-1.49], 
obese women (OR 1.70; 95%CI 1.34-2.15) and severely obese women (OR 3.11; 95% 
CI 1.75-5.46).17 The findings in these studies however, are confounded by several 
limitations. These include a variable degree of antenatal detection of congenital 
anomalies between different centres, failure to diagnose and adjust for maternal diabetes, 
and the use of different systems in the classification of obesity. There is also a 
significant impairment of adequate ultrasound visualisation of fetal anatomy as BMI 
increases and this is mostly marked for cardiac and craniospinal structures.17-19 Maternal 
obesity also increase the likelihood that more than one ultrasound scan will be required 
for a fetal anomaly survey, thereby impacting on the service provision and is costly for 
the patient.17-19 
 
Population based cohort studies have reported an increased risk of preterm birth in obese 
women. Women with pre-pregnancy BMI ≥ 30kg/m² were at increased risk of preterm 
delivery (delivery before 37 completed weeks gestation) compared to lean women, with 
an OR of 1.6 (95% CI 1.2-2.1). This increased risk remained significant when women 
with diabetes, hypertension or preeclampsia were analysed separately (OR1.5; 95% CI 
1.1-2.1) 20 The above finding was echoed by a meta-analysis which showed that the risk 
of preterm delivery increased with higher grades of obesity. Adjusted odds ratio (AOR) 
on overweight, obese and morbidly obese compared to normal weight were: 0.85 (95% 
CI: 0.80-0.92), 1.33 (95% CI: 1.12-1.57) and 2.27 (95% CI: 1.76-2.94) respectively.18 
The increase in the risk of preterm delivery could be explained by obesity related 
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medical and antenatal complications that often lead to elective delivery rather than an 
intrinsic predisposition to spontaneous preterm birth.9-15,21  
 
Pre-pregnancy obesity and maternal weight gain during pregnancy both play a vital role 
in determining infant birth weight. Several studies have shown that there is a linear 
relationship between increasing pre-pregnancy weight and birth weight. 22 Macrosomia 
(birth weight > 4.0kg) is commonly seen in obese women, and it is a recognised risk 
factor for the development of shoulder dystocia, which can subsequently result in both 
maternal and fetal trauma.9-15,22-24 In shoulder dystocia even if there is an expedited 
delivery, brachial plexus injuries and bone fractures are still encountered.9-15 
Epidemiological studies have shown a continuum from macrosomia at birth to the 
development of childhood obesity and its associated metabolic complications of diabetes 
and hypertension.25-26 Several cohort studies have shown that pre-pregnancy weight loss 
to a normal BMI reduces the risks of having a macrosomic infant.27  
 
An association between perinatal mortality and high BMI has also been documented. In 
a meta-analysis (nine controlled trials) it was shown that overweight and obese pregnant 
women experienced significantly more stillbirths than normal weight women: 
overweight women unadjusted OR 1.47( 95% CI 1.08-1.94), and  obese women 
unadjusted OR 2.07(95% CI 1.59-2.74).28   Several hypotheses have been postulated to 
explain the association, and these include: a) higher rates of diabetes and hypertension  
seen in obese women compared to non-obese and these conditions contribute 
significantly to occurrence of stillbirths, b) metabolic changes associated with obesity, c) 
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decreased awareness of fetal movements, d) nocturnal apnoea with transient oxygen 
desaturation. Several studies have shown that even if there is adjustment for diabetes and 
hypertension as major confounding factors to stillbirth, the stillbirth rates are still high in 
the obese population. This has been attributed to fetal growth restriction associated with 
histological placental dysfunction seen in obese women.9-15,28     
 
Due to small numbers in some of the perinatal outcomes observed some authors have 
resorted to have a composite score when assessing adverse perinatal events for obese 
pregnant women. 9-15 An example for a composite score of adverse perinatal events 
would include one or more of the following: macrosomia, shoulder dystocia, congenital 
abnormalities and perinatal deaths.  
 
Maternal outcomes 
In the United States (US), studies have shown that in obese pregnant women there is a 6 
to 12 percent increase in gestational diabetes as compared to a 2 to 4 percent increase in 
the general population. 9-15 Due to the association between obesity and gestational 
diabetes, prenatal care units in the US screen all obese pregnant women for gestational 
diabetes. The US studies  show that there is an increased risk of type 2 diabetes in obese 
women due to an exaggerated increase in insulin resistance.  Prenatal units in the US 
also  screen for pre-gestational diabetes using the following risk factors: marked obesity, 
personal history of gestational diabetes, glycosuria, strong family history of diabetes. 29 
Gestational diabetes usually resolves postpartum however obese women have a two fold 
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increased prevalence of subsequent type 2 diabetes compared with women with a normal 
BMI. 30 
 
An association between obesity and hypertensive disorders in pregnancy has been 
consistently reported. In addition, maternal weight and BMI are independent risk factors 
for preeclampsia and other hypertensive disorders. 31 A review of 13 cohort studies 
comprising nearly 1.4 million women found that the risk of preeclampsia doubled with 
each 5 to 7kg/m² increase in pre-pregnancy BMI. 32 This observation persisted in studies 
that excluded women with chronic hypertension, diabetes mellitus, multiple pregnancy 
and other confounders. Weight loss pre-pregnancy significantly reduces the risk of 
preeclampsia as was evidenced in women who underwent bariatric surgery.27 The 
mechanism whereby obesity imparts an increased risk for preeclampsia is not clearly 
understood.  Current hypotheses suggest that pathophysiological changes associated 
with obesity related cardiovascular risk such as insulin resistance, hyperlipidaemia and 
subclinical inflammation are responsible for the increased incidence of preeclampsia in 
obese pregnant women. 31-34 
 
Cohort studies have illustrated that obese women have prolonged labours. In a study of 
509 nulliparous women undergoing induction of labour it was shown that as maternal 
weight increased, the rate of cervical dilatation decreased and the induction to delivery 
interval lengthened. 35 A similar relationship was echoed in a cohort of 612 nulliparous 
women who delivered following spontaneous labour. 36 The mean duration of labour 
from a cervical dilatation of  4 cm  to 10 cm was significantly longer for both 
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overweight and obese women, compared to normal weight women (7.5, 7.9 and 6.2 
hours respectively). A study that measured intrauterine pressures during labour showed 
that obese women did not have a significant reduction in baseline uterine contractility or 
uterine pressures generated during valsalva compared to non-obese control. 37 The active 
phase of labour was significantly longer in obese women, suggesting that active phase 
rather than second stage labour characteristics may be more significantly impacted by 
maternal weight. This theory has been supported by studies which have shown that 
samples of myometrium taken from obese women at caesarean delivery contracted less 
well in vitro than myometria obtained from normal weight women. 38 Although there is 
currently inadequate data to establish weight based criteria for labour management,  it 
has been suggested that, providing maternal and fetal status are reassuring,  the clinician 
could adjust his or her expectations of normal labour progress to allow for a longer 
active phase and second stage of labour in obese women.  
 
Due to prolonged labour in obese women there is increased frequency in caesarean 
delivery for cephalopelvic disproportion or failure to progress. 35,36,39 It has also been 
hypothesized that obesity may lead to dystocia due to increased soft tissue deposition in 
the maternal pelvis. 40 Pre-pregnancy obesity and excessive weight gain before or during 
pregnancy contribute to an increased probability of caesarean delivery. 40-42 Caesarean 
delivery in obese pregnant women is associated with a number of perioperative concerns 
which are: difficulty in placement of regional anaesthesia, difficult intubation following 
failed regional anaesthesia with concerns of aspiration, emergency delivery, prolonged 
incision to delivery interval, postpartum haemorrhage (blood loss >1000ml), longer 
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operative times, wound infection, thromboembolism and endometritis. 43-44 The relative 
contribution of maternal, intrapartum and surgical factors to perioperative morbidity in 
the obese population is not clearly defined.  One study suggested that difficulties 
encountered when operating in obese women lead to lapses in surgical technique and 
inadequate haemostasis, with a resultant increase in wound complications. 43-44 
 
Obesity is a risk factor for thromboembolism both in the antenatal and postnatal periods. 
In first world countries thromboembolic events is responsible for a high proportion of 
maternal deaths. 45 Of the 33 women who died from pulmonary embolism in the UK 
between 2003 and 2005, 12 (36%) were obese. Although data is limited, obesity has 
been shown to be associated with a high risk of pulmonary embolism (AOR 14.9, 95% 
CI: 3.0-74.8) and deep vein thrombosis (AOR 4.4, 95% CI: 1.6-11.9) compared to 
normal BMI. 43-45 Thromboprophylaxis guidelines have been instituted to prevent such 
events in the general population as well as in the pregnant population. They start by 
ambulation, adequate hydration, thromboembolic deterrent stockings and providing low 
molecular heparin as per risk score analysis. 43-45    
 
Obesity is associated with increased rate of postpartum haemorrhage (PPH).9-15 Policy 
guidelines have been drafted that recommend all obese women to have active 
management of third stage of labour as PPH is one of the preventable causes of maternal 
deaths. A population based cohort study of over a million women with singleton 
pregnancy demonstrated that the risk of PPH due to uterine atony increased rapidly with 
increasing BMI, however no link was found with retained placenta. For morbidly obese 
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women there was an increased risk for PPH following a normal delivery (OR 1.23, 95% 
CI: 1.04-1.45) compared with women with normal BMI. This was even more 
pronounced when assisted vaginal delivery was instituted (OR 1.69, 95% CI: 1.22-
2.34).46 
 
Pre-conception weight loss 
In an ideal setting, a normal weight should be achieved prior to pregnancy, as this would 
avoid potentially negative outcomes. Although health care experts support the idea that 
obese women should lose weight preconceptionally, this has not been tested in a clinical 
trial. The following obstacles have been encountered when trying to promote 
preconception weight loss: a) It has been noted that nearly half of pregnancies in the 
USA are unplanned, hence no preconception counselling is instituted, b) Contraception 
can be used to delay pregnancy while trying to lose weight but oestrogen containing 
contraceptives are contraindicated in obese hypertensive women, and c) It has been 
reported that the efficacy of contraception in obese clients is reduced, which could 
consequently result in unplanned pregnancies.49  If pre-pregnancy weight is not 
controlled in the near future, the prevalence of obesity in pregnancy will rise further. 
 
 
RATIONALE OF THE STUDY 
Obesity has been declared a worldwide epidemic and although its effects in pregnancy 
have been extensively evaluated in well to do resource settings, there is less data from 
poorly resourced settings such as sub Saharan Africa. It was our proposal to assess the 
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impact of obesity on perinatal outcomes in pregnant women booking for antenatal care 
from the Guguletu, and Mitchell’s Plain residential areas. The study also planned to 
estimate the prevalence of obesity in these two drainage areas and to describe adverse 
maternal outcomes associated with obesity.  
 
STUDY OBJECTIVES 
The study aimed to: 
a) Measure the prevalence of obesity in all women who book for antenatal care from 
Guguletu and Mitchell’s Plain drainage areas 
(b) Compare the incidence of adverse perinatal outcomes in pregnant women with high 
BMI compared to those with normal BMI 
(c) Describe the incidence of adverse maternal events in women with high BMI and 
women with normal BMI  
 
METHODS  
Study design 
This was a retrospective observational study that compared perinatal outcomes in 
women with normal pregnancy BMI to outcomes in women with high pregnancy BMI. 
 
Study population 
The study population included pregnant women residing in the Guguletu and Mitchell’s 
Plain residential areas who booked at Guguletu MOU (GMOU) and Mitchell’s Plain 
MOU (MPMOU) during January to April 2011.  Mitchell’s Plain is a middle income 
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community with a population of 398 650, of which 66.2% are coloured, 33% black 
African, and the remainder being white, Indian or Asian. Guguletu is a low 
socioeconomic status community with a population of 80 277. This is made up of 
predominantly 98.8% black African, and 1.1% coloured ethnic groups. In the two study 
populations, at least 51% are female. 50       
 
 
Study setting 
The majority of women in these two areas book for antenatal care at the local MOU or 
Basic AnteNatal Care (BANC) primary clinic. These two midwife obstetric units 
(MOUs) provide maternity care services at primary level with a combined total of about 
6000 deliveries per annum. A further 4500 per annum deliver at Mowbray Maternity 
Hospital which is the referral secondary level hospital for these two MOUs. Tertiary 
care is catered for by Groote Schuur Hospital, accounting for approximately 1500 
deliveries as referrals per annum from these two MOUs.   A small number of women 
who have had problems in a previous pregnancy book directly at secondary level 
(MMH) and tertiary level (GSH). Of the larger group that book at the primary level 
MOU or BANC clinic, women who are assessed to be higher risk and/ or develop 
complications during antenatal care will be referred for delivery at MMH or GSH 
depending on the severity of the problem. Additionally some women will be referred on 
to secondary level or tertiary level hospital intrapartum or postpartum. Annual delivery 
statistics indicate that approximately 48% of deliveries occur at primary level, 37% at 
secondary level and 15% at tertiary level 
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Inclusion criteria 
Pregnant women residing  in Guguletu and Mitchells Plain who booked  at Guguletu and 
Mitchells Plain MOUs in the first or second trimester, with a singleton pregnancy  and 
gestational age less than  30 weeks. Gestational age was assessed by dating from the last 
first day of the last normal menstrual period and/or obstetric ultrasound scan done during 
the antenatal care.  
 
Exclusion criteria 
Pregnant women with pre-existing hypertension and diabetes, multiple pregnancies, and 
miscarriages before 20 weeks gestation were excluded from the comparative part of the 
study since these conditions are known to have an independent effect on perinatal 
outcomes. Underweight women as defined by BMI ≤18.49 were also excluded from the 
comparative part of the study as underweight is also a potential confounder on adverse 
perinatal outcomes. 
 
Process of data collection 
A list of folder numbers was retrospectively compiled from the antenatal booking 
registry of all pregnant women who booked for antenatal care at the specified sites 
during the study period (1 January to 30 April 2011). From the list, maternal folders 
were tracked by using the CLINICOM electronic tracking system, MOU delivery 
registers, antenatal clinic transfer registers and labour ward transfer registers to find the 
place of delivery or outcome of the pregnancy. Once folders were identified, maternal 
and neonatal characteristics were assigned a study number as a mother/ infant pair.  
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Mother infant pairs were retrospectively tracked to the end of the pregnancy. All 
required characteristics were extracted and entered into the data collection sheet and 
later on filtered as to the inclusion and exclusion criteria of the study. The tracking 
system enabled us to follow women that were referred to secondary or tertiary level care 
in their pregnancy as well as those that were referred back to the MOUs. 
 
Maternal data was extracted from the maternity case record books, and admission and 
delivery registers kept at the delivery facility. Maternal characteristics that were 
extracted  included age, gravidity, parity, height and weight at booking, gestational age 
at booking, HIV status, obstetric scan done in pregnancy, gestation age at delivery, pre-
existing medical conditions noted at booking (hypertension and diabetes), development 
of hypertension and diabetes in pregnancy, mode of delivery including the indication, 
occurrence of perineal tears, postpartum haemorrhage (PPH), diagnosis of 
thromboembolic events, prolonged hospital stay ( > 5 days) and diagnosis of sepsis 
within 5 days postpartum. See appendix A. 
 
Corresponding neonatal data was extracted from neonatal folders and delivery registers. 
Neonatal characteristic extracted included sex, birth weight, 5 minute Apgar scores at 
delivery, occurrence of shoulder dystocia, congenital anomalies (neural tube and cardiac 
defects), perinatal deaths (stillbirth and neonatal death within 7 days of life) and 
admission to the neonatal intensive care unit (NICU) with indications included. (Apgar 
score <7 in 5 minutes, macrosomia, complications from shoulder dystocia) See appendix 
A. 
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Study outcomes 
As noted from the literature, adverse perinatal outcomes can be evaluated individually or 
as a composite score in view of small numbers in some of the events. In our study the 
primary study outcome was a composite of the following perinatal events:  
1) Perinatal death (stillbirth or neonatal death within 7 days of life),  
2) Macrosomia (birth weight > 4.0kgs in our setting), 
3) Shoulder dystocia (prolongation of head to body delivery time of > 60 seconds after 
gentle traction has failed), 9-15   
4) Five minute Apgar score < 7,  
5) Congenital abnormalities (neural tube and cardiac defects).  
 
Secondary end points looked at the prevalence of obesity in the study population and 
maternal adverse events that occurred after women had been enrolled into the study. 
Maternal adverse events included the development of hypertension and diabetes in 
pregnancy, caesarean section, assisted delivery, third and fourth degree perineal tears, 
PPH, thromboembolism and prolonged hospital stay of more than 5 days.  
See appendix A for the data collection forms. 
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Sample size 
The sample size calculation based on the occurrence of the composite outcome showed 
the required sample to be 1109 based on a 95% confidence level with a power of study 
set at 80%. An interim analysis was planned to assess the effect of obesity on perinatal 
outcomes. We anticipated that in the study population 25% would be classified as obese 
and in the obese group there would be 10% prevalence of adverse perinatal outcomes 
and the odds of adverse event was 2.1 in the obese group.51-52 From the unexposed group 
(normal BMI) we anticipated that there would be a 5% prevalence of the perinatal 
outcomes. Our exposed group was the high BMI categories and the unexposed/ control 
group was the normal BMI group. 
 
Statistical analysis 
 Data was analysed by STATA MP 11: StataCorp. 2009. Stata Statistical Software: 
Release 11. College Station, TX: StataCorp LP.  
Comparisons were drawn between the normal BMI and the increased BMI groups 
(overweight, obese and morbidly obese).  Descriptive and inferential statistics were used 
for the data analysis. Chi-square and / or Fisher exact tests were computed to assess the 
effect of maternal BMI on perinatal and maternal outcomes. We examined the effect of 
age on increase in BMI by Kruskall-Wallis test. Univariate logistics regression models 
were used to assess the unadjusted odds ratio of an event (maternal or perinatal) 
occurring in the respective BMI categories and having accounted for possible 
confounders multivariate logistics regression models were employed to give the adjusted 
odds ratios (AOR). Statistical analysis used normal BMI as the reference and p value < 
0.05 was taken as level of significance. Variables used in the models were maternal age, 
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parity, gestational age at delivery, weight and height, perinatal and maternal outcomes.  
In particular age, parity, hypertension, gestational diabetes and HIV are known to 
influence perinatal outcome and the influence of these were adjusted for in the statistical 
analysis.  
 
 
 
Ethics 
Ethical approval was granted by the Human Research Ethics Committee of the 
University of Cape Town (reference number HREC 463/2012 see appendix B)  and 
permission to conduct the research at the respective delivery units was obtained from the 
research committee of the Provincial Government of the Western Cape (2012 RP 150 
see appendix C).  
 
Strict confidentiality was practised and no maternal direct identifiers like names and 
contact details were entered in the working data sheet. Maternal folders were not taken 
out of the delivery units. Study participants were assigned study numbers throughout the 
study period and transfer of participants’ information from folders was only done by the 
study investigator. Since the study was retrospective in nature and involved folder 
review and no patient contact, no consent was needed from the participants. 
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RESULTS 
 
During the study period 1350 women were noted to have been entered into the booking 
registry from January to the end of April 2011, of which 150 folders were missing.  Of 
the 1200 folders that were reviewed 230 were excluded as per the exclusion criteria in 
the methods section (14 preexisting medical problems, 22 were underweight, 53 missing 
variables, 141 booked after 30 weeks) and 970 folders were analysed for the 
comparative component of the study (see Figure 1). From the analysed folders, 820 of 
the participants delivered at the MOUs, 30 delivered at the tertiary institution and 120 
delivered at secondary level care as shown by figure 1.  
 
An interim analysis was done on the first 1350 folders of the women that booked at the 
two MOUs and the final folders of 970 that were used for the comparative analysis 
showed significant adverse effect of obesity on perinatal outcomes hence we did not 
proceed to look for the remainder of the sample size (1109). Possible explanations for 
the interim analysis findings was that we underestimated the prevalence of obesity in our 
population as well as the effect of maternal obesity on perinatal outcomes as will be 
revealed by the results below. 
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Figure 1. Number of folders reviewed and the application of inclusion and exclusion criteria 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1350 women booked at the MOUs 
1200 folders reviewed 
EXCLUSION 
150 folders missing 
970 mother infant pairs were analysed 
EXCLUSIONS 
14 medical problems pre preg 
22 were underweight 
44 had missing variables for BMI 
9 had other missing variables  
141 booked after 30 weeks gest 
 
30 delivered at a tertiary 
institution ( Groote Schuur 
Hospital)  
120 delivered at Level 2 
institution (Mowbray 
Maternity Hospital ) 
820 MOU DELIVERIES 
487 Mitchells’ Plain 
333 Guguletu 
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 Table one shows the prevalence of obesity in the study population to be 40.4%; and 
provides a breakdown of the study group into BMI categories. For calculating the 
obesity rate the denominator used was 1015 which included all categories of BMI (970 
plus 22 underweight women) and the 14 women with medical problems noted at the 
booking visit and  the 9 women with  other missing variables but had weight and height 
documented. Twenty two (2.2%) women were classified as underweight, 386 (38.0%) 
had normal BMI, 197 (19.4%) were overweight and 410 (40.4%) were obese. (Table 1 
and Figure 2). Comparing the two MOUs, MPMOU had more obese women than 
GMOU 40.6% vs 35.4% and GMOU had more overweight women than MPMOU 20.2% 
vs 15.7%. (Table 1) 
 
Table 1: Prevalence of obesity in the study population. 
BMI 
MPMOU 
n(%) 
GMOU 
n(%) 
Group   Total 
n (%) 
Underweight 15(3.0)   7(1.0) 22(2.2) 
Normal 200(40.7) 186(31.4) 386(38.0) 
Overweight 77(15.7) 120(20.2) 197(19.4) 
Obese 200(40.6) 210(35.4) 410(40.4) 
TOTAL 492 (100) 593(100) 1015(100) 
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Figure 2: Prevalence of obesity in the study group 
 
When the obese group was split into obesity and morbidly obese, our study showed that 
12.4% were morbidly obese.(Figure 3).   
Figure 3: Prevalence of obesity in the study cohorts with obese group split into obesity 
and morbidly obese.
 
 
2.20% 
38.00% 
19.40% 
40.40% 
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
Underweight Normal Overweight Obese
BMI  
2.20% 
38.00% 
19.40% 
28.00% 
12.40% 
0%
5%
10%
15%
20%
25%
30%
35%
40%
Underweight Normal Overweight Obesity Morbidly
Obese
BMI 
33 
 
For the comparative analysis of perinatal and maternal outcomes in women with high BMI 
compared to normal BMI, the underweight women were excluded from the analysis; giving a 
total group of 970 that were further analysed .The following figures and tables refers to the 
further analysis of 970 cases. 
 
Table 2. Maternal characteristics for the study cohort  
Study sample descriptives n= 970 
 
  Maternal characteristics n (%) 
Age (years)median (IQR) 25(21-29) 
Parity,  
 Primiparous 247(25.5) 
One previous pregnancy 378(40.0) 
More than one previous pregnancy 345(35.5) 
Gestational age at booking  
 Less than 20 wks 419(43.0) 
20-29.9 wks 551(57.0) 
Gestational age at delivery  
 Less than 37 completed wks 95(9.8) 
38-41+ wks 875(90.2) 
At least one obstetric scan  826(85.2) 
Mode of delivery   
Vaginal delivery 866(89.3) 
Instrumental delivery 6(0.6) 
Caesarean section 98(10.1) 
Hypertension in pregnancy  40(4.1) 
Gestational diabetes  17(1.8) 
HIV   
Positive  150(15.5) 
Negative  820(84.5) 
Perineal tears   
≤ second degree  960(99.0) 
≥ third degree  10(1.0) 
PPH  53(5.5) 
  
 
34 
 
Median age of the study cohorts was 25 (IQR 21-29), 247(25.5%) of the participants 
were primiparous, 378 (40.0%) had one previous pregnancy and 345 (35.5%) had more 
than one previous pregnancy. Median age was used as the data was not normally 
distributed.  On gestational age at booking 419 (43.0%) participants booked when they 
were less than 20 weeks and 551 (57.0%) booked between 20 -29.9 weeks of gestation. 
At least 826 (85.2%) of the study participants had an obstetric scan during their entire 
pregnancy. Gestational age at booking was assessed by menstrual dates if they were sure 
or an early obstetric scan was used to give an estimate date of delivery. 95 (9.8%) of the 
women had a preterm delivery, 866 (89.3%) attained a vaginal delivery with the 
incidences of instrumental and caesarean section delivery being 0.6% and 10.1% 
respectively. From the study population 150 (15.5%) women were HIV positive and 
1.0% of the women sustained at least a third degree perineal tear. 4.1% of the study 
population developed hypertension after the booking visit and 1.8 % developed 
gestational diabetes in pregnancy.(see Table 2) 
 
The data on median age at booking assessed by Kruskal- Wallis test showed that higher 
BMI was significantly associated with a higher age (p = 0.0001) as shown by table 3 and 
figure 3. Post hoc pairwise tests (Mann-Whitney) also showed that a difference existed 
in BMI for older women and this was statistically significant when women with normal 
BMI category were compared to overweight, obese and morbidly obese groups. The 
differences were also seen when overweight women were compared to obese and 
morbidly obese groups and these differences were statistically significant. (all calculated 
p- value < adjusted ref p-value of 0.0083, see table 4). However when obese group of 
35 
 
women were compared to the morbidly obese, the difference was not statistically 
significant. (calculated p > adjusted ref p value of 0.008) 
 
 
Table3. Showing age distribution within BMI categories (p= 0.0001 by Kruskal Wallis 
test.) 
Age by categories of BMI 
  BMI  N Minimum Maximum Median 
25th 
Percentile 
75th 
Percentile 
Normal 384 14 42 22 20 26 
Overweight 197 14 44 25 21 29 
Obese 271 16 45 27 23 32 
Morbidly Obese 118 16 41 26 24 31 
Total 970 14 45 25 21 29 
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  Figure 4: Box and whisker plot indicating median values, IQR and range of age for 
each category of BMI. 
 
  Table 4. Further analysis by Mann-Whitney pairwise tests showing age differences 
within BMI categories. 
BMI 
Category Vs. Test statistic P-value Adjusted Ref p-value 
Normal 
Overweight z = -5.081 <0.0001 0.008333 
Obese z = -9.844 <0.0001 0.008333 
Morbidly Obese z = -7.592 <0.0001 0.008333 
Overweight 
Obese z = -4.068 <0.0001 0.008333 
Morbidly Obese z = -3.032 0.0024 0.008333 
Obese Morbidly Obese z = 0.535 0.5926 0.008333 
10
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15.5% of the study cohort were HIV positive (Table 2) and among the HIV positive group obese 
women were more likely to be HIV positive. This association was statistically significant 
(P=0.000) see figure 5. 
Figure 5:  Prevalence and association of HIV and BMI where N depicts HIV negative and P for 
HIV positive subjects.
 P=0.000 
 
Perinatal outcomes 
Table 5. Perinatal outcomes by Body Mass Index Categories 
   
 
                    
                Body Mass Index Category 
  Normal Overweight Obese Morbidly obese 
Outcome n=378 n=197 n=271 n=118     P 
      
Birth weight ≥4kg 16(4.2) 11(5.6) 34(12.6) 29(24.6) 0.000 
Shoulder dystocia 3(0.8) 1(0.5) 5(1.9) 11(9.3) 0.000 
Perinatal deathⁿ 6(1.6) 0 7(2.6) 12(10.2) 0.000 
NICU admission 11(2.8) 5(2.5) 11(4.0) 25(21.2) 0.000 
Apgar, 5 min < 7 6(1.6) 2(1.0) 6(2.2) 8(7.6) 0.008‡ 
Congenital abnormalities† 0 0 3(1.1) 11(9.3) 0.000‡ 
At least one Perinatal eventᶬ 30(7.8) 15(7.6) 52(19.2) 55(46.6) 0.000 
      
‡Analysis was done using Fischer's exact test 
   † Cardiac and neural tube defects 
    ⁿStill births and early neonatal deaths 
    ᶬ Cumulative outcome 
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This study showed that birth weight ≥ 4kg, shoulder dystocia, perinatal death, NICU 
admission, 5 minute Apgars < 7, congenital abnormalities and perinatal events were 
significantly more frequent as BMI categories increased from normal to morbidly obese. 
(all variables p < 0.05, see Table 5).  
When 3 BMI categories were analysed [normal, overweight and obese (BMI≥30)] obese 
women had unadjusted odds ratios for macrosomia 4.4(2.52-7.85), perinatal death3.24 
(1.23-8.19), shoulder dystocia 5.45 (1.57-18.85), ICU admission 3.46 (1.73-6.90), 
preterm delivery 1.66 (1.04-2.65) and perinatal event 4.48(2.9-6.91) which were all 
significant (see Table 6).  
 
Table 6. Unadjusted odds ratios and 95% confidence intervals for perinatal outcomes for high 
maternal BMI in comparison to normal BMI, where obese included all BMI ≥ 30kg/m² 
  
Maternal BMI at booking 
 
normal weight 
      (n=384) 
Overweight 
(n=197) 
Obese 
(n=389) 
Birth weight ≥4kg (n=970) 1 1.36(0.62-2.99) 4.44(2.52-7.85) 
Perinatal death (n=970) 1 ¥ 3.24(1.23-8.19) 
Shoulder dystocia (n=970) 1 0.65(0.07-6.27) 5.45(1.57-18.85) 
ICU admission (n=970) 1 0.88(0.30-2.58) 3.46(1.73-6.90) 
preterm delivery (n=970) 1 0.71(0.36-1.42) 1.66(1.04-2.65) 
perinatal event (n=970) 1 0.97(0.51-1.85) 4.48(2.9-6.91) 
    ¥ overweight subjects not used as they were no perinatal deaths observed in this cohort 
 
 
 
 
Splitting BMI ≥ 30 into obese and morbidly obese as per WHO criteria unadjusted odds 
ratios were significant for all outcomes in the morbidly obese group with normal BMI 
used as a reference category (see Table 7). However the unadjusted odds ratios with 
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95% CI in the obese category for perinatal death, shoulder dystocia, ICU admission, 
preterm delivery were not significant [1.67(0.55-5.03), 2.39 (0.56-10.08), 1.44 (0.61-
3.36), 1.27 (0.74-4.53) respectively] but the unadjusted odds ratios with 95% CI for 
macrosomia 3.30 (1.78-6.11) and perinatal events 2.80 (1.73-4.53) were significant in 
the obese group (see Table 7). Unadjusted odds ratios for neonatal outcomes in the 
overweight group were not significantly different from the normal weight category (see 
Table 7). 
Table 7. Unadjusted odds ratios and 95% confidence intervals for perinatal outcomes for high maternal 
BMI in comparison to normal BMI with BMI ≥ 30kg/m² split into obesity and morbidly obese 
 
 
Maternal BMI at booking 
 
 
 
 
normal 
weight overweight obesity morbidly obese 
 
 
(n = 384) (n = 197) (n = 271) (n = 118) 
 Birth weight≥4kg (n=970)      1 1.36 (0.62-2.99) 3.3 (1.78-6.11)† 7.49 (3.90-14.40)† 
Perinatal death (n=773)      1 ¥ 1.67 (0.55-5.03) 7.13 (2.62-19.45)† 
Shoulder dystocia (n=970)      1 0.65 (0.07-6.27) 2.39 (0.56-10.08) 13.06 (3.58-47.64)† 
ICU admission (n= 970)      1 0.88 (0.30-2.58) 1.44 (0.61-3.36) 9.11 (4.33-19.19)† 
Preterm delivery (n=970)      1 0.71 (0.359-1.42) 1.27 (0.74-2.16) 2.66 (1.49-4.77)† 
 perinatal events (n=970)      1 0.97 (0.51-1.85) 2.80 (1.73-4.53)† 10.3 (6.13-17.32)† 
      † Indicates unadjusted odds ratio that was statistically significant 
  normal weight used as a reference category 
   ¥ overweight subjects not used as they were no perinatal deaths observed in this cohort, 
   
Having accounted for age, parity, hypertension in pregnancy, gestational diabetes and 
HIV, morbidly obese women had high significant adjusted odds ratios for macrosomic 
deliveries 9.2(4.61-18.55), perinatal deaths 9.0 (3.04-27.04), shoulder dystocia 36.6 
(8.94-149.40), ICU admission 10.25 (4.82-23.95), preterm delivery 2.3 (1.2-4.15) and 
perinatal events 12.34 (7.02-21.69)(see Table 8). However, though perinatal outcomes in 
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the morbidly obese group were statistically significantly higher compared to normal 
BMI, they had wide confidence intervals. Obese women were 4.7 times more likely to 
have a macrosomic delivery, 5.5times more likely to encounter shoulder dystocia and 
3.9 times more likely for a perinatal event to happen when compared to the normal 
weight group and all these observations were statistically significant. However odds for 
perinatal death (2.48), ICU admission (1.71) and preterm delivery (1.1) were not 
significant in the obese group (see Table 8). Though the adjusted odds for preterm 
delivery were 31% lower in overweight group this was not statistically significant (see 
table 8). 
Table 8. Adjusted odd ratios and 95% confidence interval for perinatal outcomes for high maternal  
BMI in comparison to normal BMI 
 
 
Maternal BMI at booking 
 normal weight overweight obesity morbidly obese 
 
(n = 384) (n = 197) (n = 271) (n = 118) 
Birth weight ≥4kg  * 1 1.69 (0.76-3.77) 4.71 (2,45-9.06) 9.24 (4.61-18.55) 
Perinatal deathʱ 1 £ 2.48 (0.78-7.86) 9.07 (3.04-27.04) 
Shoulder dystocia* 1 0.97 (0.10-9.50) 5.49 (1.25-24.16) 36.56 (8.94-149.40) 
ICU admission* 1 0.97 (0.32-2.86) 1.71 (0.70-4.17) 10.75 (4.82-23.95) 
Preterm delivery* 1 0.69 (0.34-1.37) 1.10 (0.68-1.95) 2.26 (1.20-4.15) 
Perinatal event* 1 1.14 (0.59-2.20) 3.9 (2.31-6.55) 12.34 (7.02-21.69) 
 
Adjusted odds ratio (AOR) having accounted for age, parity, hypertension and gestational diabetes in  
pregnancy and HIV. Normal weight used as the reference category. P < 0.005 
£ no perinatal death was observed in the overweight group 
*n= 970 
    ʱ n= 773 
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Maternal outcomes 
Table 9. Maternal outcomes by Body Mass Index categories 
   
 
Body Mass Index Category (kg/m²) 
 Normal  Overweight Obesity Morbidly Obese 
Outcome (n=384) (n=197) (n=271) (n=118)      P 
Mode of delivery  n (%) n (%) n (%)   n (%)           0.000 
    Vaginal delivery  372(96.8) 175(88.8) 231(85.2) 88(74.6) 
     instrumental delivery  1(0.3) 1(0.5) 3(1.1) 1(0.9) 
     caesarean section  11(2.9) 21(10.7) 37(13.7) 29(24.6) 
 Perineal tears‡  2(0.5) 0 3(1.1) 5(4.2)  0.005 
Gestational age at delivery† 32(8.3) 12(6.1) 28(10.3) 23(19.5)  0.001 
Medical problems in pregnancyⁿ  8(2.0) 22(11.2) 22(8.1) 21(17.8)  0.000 
Thromboembolism  0 0 2(0.7) 0 0.251 
      ‡ third or fourth degree tears 
     † less than 37 complete weeks  
     ⁿ hypertension in pregnancy and gestational 
diabetes 
     
 
In terms of mode of delivery, 98 (10.1%) of the 970 women were delivered by caesarean 
section (Table 2) Morbidly obese women had a higher incidence (24.6%) of caesarean 
delivery which was significant (p= 0.000) (Tables 9). As the BMI category increased the 
proportion of preterm deliveries also increased from 6.1% in overweight category to 
19.5% in morbidly obese women and this was significant (p= 0.001). There was also a 
significantly increased number of third degree perineal tears with higher BMI (p= 0.005, 
Table 9). The incidence of thromboembolism in high BMI groups was not significant in 
this study (p=0.251, Table 9). This study cohort showed an increase in maternal medical 
problems in pregnancy with an increase in BMI which was statistically significant (p = 
0.000, Table 9).  
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Table 10. Unadjusted odds ratios and 95% confidence intervals for maternal outcomes for high 
maternal BMI in comparison to normal BMI with all BMI ≥ 30kg/m² classified as obese 
 
Maternal BMI at booking 
 
Normal weight Overweight Obese 
(n=384) (n=197) (n=389) 
Hypertension in 
pregnancy 
1 2.38(0.72-7.90) 6.11(2.34-15.95) 
Gestational diabetes 1 ¤ 4.74(1.35-16.63) 
Mode of delivery 
Perineal tear ≠ 
1 
1 
4.06(1.91-8.60) 
¥ 
7.00(3.63-13.48) 
2.5(0.76-11.40) 
¤ no gestational diabetes was observed in the overweight group. 
¥ overweight group did not sustain third degree perineal tears 
≠ at least third degree perineal tear 
 
Unadjusted odds ratios with 95% CI for developing hypertension, gestational diabetes in 
pregnancy, sustaining at least third degree perineal tears and being delivered by 
caesarean section among the obesity group (BMI ≥ 30) were 6.1 (2.34-15.95), 4.7 (1.35-
16.63), 2.6 (0.62-8.76), 7.0 (3.6-13.48) respectively. See table 10. Morbidly obese 
women were more likely to develop hypertension (7.8 times), gestational diabetes (11.8 
times), sustain third degree perineal tears (8.5 times) and be delivered by caesarean 
section (11.2 times) when compared to the normal weight women and this was 
statistically significant though with wide confidence intervals (see table 11).  
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Table 11. Unadjusted odds ratios and 95% confidence intervals for maternal outcomes for high 
maternal BMI in comparison to normal BMI with BMI ≥ 30kg/m² split into obesity and 
morbidly obese 
   
Maternal BMI at booking 
    
 
normal weight Overweight   Obesity morbidly obese 
(n=384) (n=197)    (n=271)       (n=118) 
 
 
        
Hypertension in 
pregnancy 
1 2.38(0.72-7.90) 5.39(2.00-14.71) 7.80(2.65-22.92) 
 Gestational diabetes 1          ¤ 1.9(0.42-8.57) 11.76(3.18-43.49) 
 Mode of delivery 1 4.06(1.91-8.60) 5.42(2.71-1085) 11.15(5.36-23.57) 
  Perineal tears ≠               1               ¥  2.10(0.36-12.88) 8.50(1.62-44.15)  
¤ no gestational diabetes was observed in the overweight group. 
≠ at least third degree perineal tear. 
¥ overweight group did not sustain third degree perineal tears 
 
 
Having adjusted for age, parity and HIV, morbidly obese women had high significant 
adjusted odds ratio for developing hypertension in pregnancy 7.80 (2.65-22.92), 
gestational diabetes 6.16 (1.57-24.20), being delivered through caesarean section 9.16 
(4.34-19.31) and sustaining a third degree perineal tear 9.33 (1.98-56.23). Though obese 
women had a 23% lower risk of developing gestational diabetes this was not statistically 
significant (Table 12).  
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Table 12. Adjusted odds ratios and 95% confidence intervals for maternal outcomes for high 
maternal BMI in comparison to normal BMI with BMI ≥ 30kg/m² split into obesity and 
morbidly obese 
 
  Maternal BMI at booking   
Normal weight overweight     obesity morbidly obese 
 
     (n=384)       (n=197)     (n=271)     (n=118) 
Hypertension in 
pregnancy 
1 2.38(0.72-7.90) 5.39(2.00-14.71) 7.80(2.65-22.92) 
Gestational diabetes 1           ¤ 0.77(0.15-3.88) 6.16(1.57-24.20) 
Mode of delivery 1 3.47(1.62-7.41) 4.07(2.00-8.35) 9.16(4.34-19.31) 
 Perineal tears ≠                 1           ¥ 2.40(0.76-13.45) 9.33(1.98-56.23) 
 
Adjusted odds ratio (AOR) having accounted for age, parity and HIV. Normal weight used as 
the reference category. P < 0.005 
¤ no gestational diabetes was observed in the overweight group. 
≠ at least third degree perineal tear. 
¥ overweight group did not sustain third degree perineal tears 
 
 
 
 
 
    
 
 
 
 
 
45 
 
 
DISCUSSION 
This was the first study done on the effects of obesity of maternal and perinatal 
outcomes in the Metro West Maternity service area. The current obesity epidemic 
presents frequent challenges to the obstetric team. From our study, the prevalence of 
obesity was 40.4%, almost similar to another South African study which had a 
prevalence of 44% but this was high as compared to the data from the USA that reported 
a prevalence of 30.5% and that of the UK of 20%.1,5-8 Prospective studies have shown 
that higher BMI is associated with older age, and this was also shown by our study. 
Reasons why there is a high prevalence of obesity could include; reduced levels of 
physical activity, high calorie intake and social stigma of associating thinness to 
HIV/AIDS. 3,4 
 
The association between higher maternal BMI and macrosomia in our study is in 
keeping with other research. 9-15 Large prospective studies have shown the risk of 
macrosomic delivery to be between 2.4 to 3.1 times higher in the obese to morbidly 
obese women compared to normal BMI; and our study showed that the adjusted odds 
ratios for macrosomia was 4.71 – 9.24 times higher compared to normal BMI. This 
difference could be explained by the high prevalence of obesity in our study population 
and also we had a small sample size compared to large population based studies. Recent 
studies have shown that the proportion of macrosomic babies have increased during the 
obesity epidemic. Strong correlations have been shown been maternal pre-pregnancy 
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weight and neonatal weight and percentage of body fat. 22-24 If pre-pregnancy normal 
BMI is attained, the risk of macrosomia is greatly reduced unless there was excessive 
weight gain in pregnancy. 27 This finding poses a great challenge in the public health 
arena as the population has to be sensitized to enter pregnancy with a normal BMI. 
Macrosomia is a recognized risk factor for developing shoulder dystocia with all its 
complications and the need for NICU admission. 9-15 Epidemiological studies have 
shown a continuum from macrosomia to childhood obesity with metabolic 
complications of hypertension and diabetes and again straining meager health care 
budgets towards curative care rather than a preventive approach which is cheaper.25-26 
Our study showed the risk of shoulder dystocia was5.45 times higher in obese compared 
to normal BMI women which was statistically significant but had very wide confidence 
intervals. This may be due to the small sample size in our study compared to others in 
the literature. When BMI ≥ 30 was split further into obese and morbidly obese the risk 
was still higher with morbidly obese but again having very wide confidence intervals. 
The risk of shoulder dystocia in the morbidly obese was 13.1 compared to normal 
weight group. This was statistically significant but again with wide confidence intervals. 
Other large studies have shown that the odds ratio for NICU admission in the obese 
group compared to normal weight women is in the range of 1.3 – 1.5, our study showed 
that the odds ratio was 1.4 but it was not statistically significant.9-12 This could have been 
because of the small numbers in the study. However morbidly obese women had 10.75 
times odds of being admitted to the NICU and this was statistically significant.  The 
majority of NICU admissions were related to intrapartum events due to difficult delivery 
associated with shoulder dystocia.  
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In the literature, there are quoted odd ratios for congenital abnormalities  of  1.6 and 3.1 
when obese and morbidly obese women respectively  are compared to normal weight.16-
17 Our study noted a significant trend of more congenital abnormalities in the obese and 
morbidly obese, but odds ratio could not be calculated as there were no congenital 
anomalies in the normal BMI group. Though the incidence of congenital abnormalities 
was statistically significant in the high BMI group, the absolute numbers were very 
small but if this is extrapolated on a larger sample size the effect might be strongly 
significant. The underlying pathophysiology is unknown but it is speculated that there is 
an altered nutritional environment for fetal development in obese women. 16 Congenital 
abnormalities occur more frequently in obese women but detection by ultrasonography 
is poor due to technically difficult scans. 18-19 Although increase in BMI has been 
associated with increase in congenital abnormalities there has been no consistency in 
reporting of these abnormalities, since some study centres did not account for all the 
confounders, the competence of ultrasonographers was different and different BMI 
categories were used in their assessments which caused data to be heterogenous. 16    
A meta-analysis has shown that obese women are at increased risk of stillbirth. 28 Large 
prospective studies have shown that the odds ratio for stillbirths is 2.1  when  obese 
women are  compared to those with normal BMI.   Our study showed an odds ratio  of 
3.2 when  the obese group (BMI ≥30) were compared to normal BMI which was 
statistically significant with wide confidence intervals. The morbidly obese group had a 
9.1 increased chance of experiencing a stillbirth after adjusting for age, parity, 
hypertension and gestational diabetes. Several reasons have been outlined as to explain 
the association between obese and high rates of stillbirths. 9-15,28 Higher rates of diabetes 
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and hypertension occur in obese women compared to the non-obese and these conditions 
contribute significantly to occurrence of stillbirths. Also, metabolic changes associated 
with obesity, decreased awareness of fetal movements due to increased abdominal wall 
adiposity and nocturnal apnoea with transient oxygen desaturation could all contribute 
towards stillbirths. Even if hypertension and diabetes are adjusted for as confounders 
stillbirth rates are still high in obese women and a number of studies have shown that the 
excess of fetal death in obese women is due to fetal growth restriction associated with 
histological placental dysfunction. 9-15,28 Customized fetal growth charts may be 
particularly valuable for detecting FGR in obese women. 28  
Population based cohort studies have reported an increased risk of preterm birth in obese 
women.21 Women with pre-pregnancy BMI≥ 30kg/m² have a 1.6 increased chance of 
preterm delivery compared to women with normal BMI. Studies have shown that this 
increased risk remained significant when women with diabetes, hypertension or 
preeclampsia were analysed separately. 21 Our study showed that the risk for preterm 
delivery was 1.7times higher in the obese group which was statistically significant and 
2.3 times higher in the morbidly obese group having accounted for the potential 
confounders. The above finding was echoed by a meta-analysis which showed that the 
risk of preterm delivery increases with higher grades of obesity. The increase in the risk 
of preterm delivery has been explained by obesity related medical and antenatal 
complications that often lead to elective delivery rather that an intrinsic predisposition to 
spontaneous preterm birth 9-15,21.  
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Difficult obstetric delivery have been associated with low 5 min Apgar scores 9-12 and 
our study showed that morbidly obese women had a higher incidence of low 5 minute 
Apgar scores. It should also be noted that an adverse perinatal event was more likely to 
occur in the morbidly obese group which poses a challenge in poor resource setting as 
this group has to be seen in an obstetrician led antenatal care unit. This has cost 
implications for the patient having to travel to level 2 or tertiary centres and in addition 
the delivery units having to be equipped with well sized equipment and the ability to 
deal with a cascade of complications associated with obesity in pregnancy. 9-11   
Prospective Studies have shown that in obese pregnant women there is a 3 times higher 
risk of developing gestational diabetes. 9-12,29 Our study showed that obese women had 
4.7 times chance of developing gestational diabetes but had wide confidence intervals 
due to the small sample size used. Postulated  reasons for high incidence of gestational 
diabetes has been the increased insulin resistance noted among the obese group. Due to 
the high prevalence of obesity, prenatal care units in the high income countries screen all 
obese pregnant women for gestational diabetes9-12 If this policy is adopted in our poor 
resource setting then that will have cost implications in the context of limited health care 
budgets. However, in Metro West maternity service area there is a customized screening 
policy for gestational diabetes that specifies the following criteria as indications for 
screening: previous gestational diabetes or 2 or more of the following: obesity, 
glycosuria, first degree family history of diabetes, previous unexplained stillborn, 
maternal age ≥40years, previous history of macrosomic delivery. 9-12  
An association between obesity and hypertensive disorders in pregnancy has been 
consistently reported and maternal weight and BMI are independent risk factors for 
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preeclampsia and other hypertensive disorders.31 Our study showed that obese women 
were 6.1 times more likely to develop hypertension in pregnancy. After accounting for 
potential confounders, the morbidly obese group was more likely to develop 
hypertension in pregnancy but had very wide confidence intervals probably due to the 
small sample size. Fifty seven percent of the women booked after 20 weeks which made 
it difficult to differentiate gestational hypertension from preeclampsia in the study 
cohort. Appropriate arm sized blood pressure (BP) cuffs should be available at all 
antenatal care facilities especially MOUs to get correct BP readings and early referrals 
made once high BPs are recorded. This is a challenge as some MOUs are not well 
equipped as evidenced by some folders that did not have BP recordings. Also early 
antenatal care booking is vital in making the diagnosis of preeclampsia but in low 
resourced settings, the majority of women have their first antenatal visit late in second 
trimester. 8,48 
 
Cohort studies have illustrated that obese women have prolonged labours and this 
consequently result in an increased frequency of caesarean delivery for labour 
dystocia.35 Our study showed that the incidence of caesarean delivery exponentially 
increased as BMI increased and also the risk of abdominal delivery was higher in the 
obese compared to the overweight group. However it should also be noted that 85.2% 
and 74.6% of obese and morbidly obese women respectively achieved a vaginal delivery 
which still shows that there is a place for vaginal delivery in high BMI groups. 
Complications of caesarean section arise from anaesthetic, intra-operative and 
postpartum period and this brings a challenge as the high BMI group is best managed in 
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a consultant led obstetric unit. This means patients have to travel extra distance from 
their households for antenatal care.43-44 To try and cater for the complications from 
caesarean section, the Metro West region referral criteria advices that obese women with 
a BMI of > 35 have to be referred for level two care from the MOUs and if they are 
morbidly obese there should be a consultation with anaesthesiologist for tertiary care 
referral.   Our study did not collect data on anaesthetic  details such as time taken to 
administer spinal anaesthesia, failed spinal and difficult intubation, and also risk of 
aspiration pneumonia observed in obese women. 
 
Although data are limited, obesity has been associated with a high risk of 
thromboembolic events but our study showed non-significant difference as we had only 
two women that developed a thromboembolic event. 43-44 The other reason why we 
observed such low numbers is that 89.3% of the study cohort had a vaginal delivery and 
got discharged 6 hours post delivery. Any further complications after discharge were 
referred to the CHC and that information would not be captured in the maternal obstetric 
notes. It should also be highlighted that our study showed that all women that were 
delivered by caesarean section did have thromboprophylaxis provided in one or all of the 
following ways; thromboembolic deterrent stockings, adequate hydration, early 
ambulation and use of low molecular weight heparin. Thus, there is a policy in place for 
thromboprophylaxis in our setting. 
 
Population based cohort studies have shown that the risk of postpartum haemorrhage 
(PPH) due to uterine atony is increased markedly with increasing BMI. 9-15 Our study 
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showed the incidence of PPH to be 5 percent which was not significant due to the small 
numbers. There is a policy in place for the management of PPH that incorporates active 
management of third stage of labour and any high risk women (fetal macrosomia, 
prolonged labor, anaemic, assisted vaginal delivery, obese women) do have an oxytocin 
infusion and/ or misoprostol immediately postpartum.  
 
Some studies have shown a continuum from macrosomia, prolonged labor and / or 
assisted vaginal delivery, shoulder dystocia to developing third or fourth perineal tears in 
the obese group. 9-15 Our study showed a statistically significant trend in the occurrence 
of perineal tears as the BMI increased. Though one cannot predict shoulder dystocia this 
calls for proper patient selection for vaginal delivery in a scenario where there is obesity, 
macrosomia and underlying gestational diabetes. Third degree perineal tear repairs of 
this nature require an experienced surgeon, theatre staff and equipment to cater for obese 
women, and in addition ward space for post-operative recovery time before discharge. 
 
Limitations of the study 
In comparison to other studies, our study had a small sample size and was retrospective 
in nature so we had no control on the loss to follow ups and missing variables. Second 
trimester bookings were common which meant that assessment of BMI may not have 
truly reflected pre-pregnancy BMI; and may have had an impact on the management of 
hypertension and GDM if diagnosed late in pregnancy. Early pregnancy losses were not 
captured in this study as they were managed in other facilities. Some participants were 
excluded because of missing variables like weight, height, and perinatal data;  this 
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reflects poor documentation and a mal-functioning birth registry. Our study may have 
missed information or other valuable confounding factors like smoking, maternal race, 
ethnicity and social class.  Weight gain in pregnancy was not recorded in the data 
collection form, although it is known to have an impact on perinatal outcomes. Our 
study focused on “lower risk” group as we excluded preexisting morbidity so the actual 
effect of obesity may be greater. Our study was not powered to look at obesity and 
medical problems in pregnancy (gestational hypertension and GDM) so the medical 
problems might have been underestimated. 
Recommendations  
There are implications of the high proportion of obese pregnant women for clinical 
practice. Women should be encouraged for early booking and also encouraged to enter 
pregnancy with normal BMI. Our study showed a relationship between high BMI and 
adverse perinatal outcomes and still echoes what other authors have been advocating for 
customized guidelines on weight gain in pregnancy in South Africa.  Every MOU should 
offer nutrition consultation to all obese women and a proper weight loss programme 
should be encouraged during and after pregnancy.  Every MOU should be equipped with 
functioning weighing scales, tape measures and appropriate sized BP cuffs. We also 
recommend a customized birth cohort registry for our setting that will pick up trends in 
the obstetric practice like any BMI changes over time in our setting. 
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CONCLUSION 
In our study, the incidence of obesity in pregnancy was high and was associated with 
adverse perinatal outcomes especially in the morbidly obese women. Obese pregnant 
women were also associated with adverse maternal outcomes. 
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